Drug discovery

How tissue plasminogen activator was discovered

Friday 27 April 2012

Interviewee/Contributer: Désiré Collen

Organisation: ThromboGenics NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Risk sharing with Pharma -- is this the way to go?

Tuesday 15 November 2011

Interviewee/Contributer: Onno van de Stolpe

Organisation: Galapagos NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Advancing a modular approach to antibody design

Sunday 23 October 2011

Interviewee/Contributer: Kevin FitzGerald

Organisation: F-Star GmbH

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Cellzome secures a lead in drug discovery

Friday 15 July 2011

Interviewee/Contributer: Tim Edwards

Organisation: Cellzome

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Critical Path Initiative at the FDA

Saturday 10 July 2010

Interviewee/Contributer: Leonard Sacks

Organisation: US Food and Drug Administration

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Noxxon Pharma AG: Through the looking glass to new therapies

Wednesday 10 March 2010

Interviewee/Contributer: Sven Klussmann

Organisation: Noxxon Pharma AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How CellCentric works in the epigenetics space

Monday 9 March 2009

Interviewee/Contributer: Will West

Organisation: CellCentric Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How Galapagos built a business from discovery

Tuesday 10 February 2009

Interviewee/Contributer: Onno van de Stolpe

Organisation: Galapagos NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Overcoming bottlenecks in drug discovery

Tuesday 10 February 2009

Interviewee/Contributer:

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How tissue plasminogen activator was discovered

Risk sharing with Pharma -- is this the way to go?

Advancing a modular approach to antibody design

Cellzome secures a lead in drug discovery

Critical Path Initiative at the FDA

Noxxon Pharma AG: Through the looking glass to new therapies

How CellCentric works in the epigenetics space

How Galapagos built a business from discovery

Overcoming bottlenecks in drug discovery

Select a News Category

Recent Appointments